So which is better?
Both are major, documented implant ecosystems. Choosing between them is a clinical and restorative decision: the surgeon's experience with the system, the site, the planned restoration and the availability of parts where you live matter more than the logo.
Reviews of implant–abutment connections found differences between connection designs in marginal bone changes, while implant survival did not clearly differ. 1819
The EFP S3 clinical guideline on peri-implant diseases centres prevention on oral hygiene, regular supportive care and managing risk factors such as smoking. 20
Frequently asked questions
Is Straumann better than Nobel Biocare?
Last updated 28 Sep 2026 · How we review
Sources
- Regulatory recordopenFDA: 510(k) clearances with applicant 'Straumann', product code DZE (69 records, 1990–2026) — U.S. Food and Drug Administration. Accessed 28 Sep 2026.
- Regulatory recordopenFDA: implant 510(k)s with applicant 'Nobel Biocare' (54 records since 1997) — U.S. Food and Drug Administration (openFDA). Accessed 28 Sep 2026.
- Regulatory recordFDA 510(k) K230108 — Straumann BLC and TLC Implants (510(k) summary) — U.S. Food and Drug Administration, 2023-09-14. Accessed 28 Sep 2026.
- Regulatory recordFDA 510(k) K142260 — NobelActive — U.S. Food and Drug Administration, 2015-05-11. Accessed 28 Sep 2026.
- Regulatory recordFDA 510(k) K202344 — TiUltra Implants and Xeal Abutments (Nobel Biocare) — U.S. Food and Drug Administration, 2020-11-16. Accessed 28 Sep 2026.
- Regulatory recordFDA 510(k) K180184 — Zeramex XT / NobelPearl Dental Implant System (Dentalpoint AG) — U.S. Food and Drug Administration, 2018-11-16. Accessed 28 Sep 2026.
- Regulatory recordFDA 510(k) K241391 — Straumann PURE Ceramic Implants — U.S. Food and Drug Administration, 2024-12-10. Accessed 28 Sep 2026.
- Manufacturer documentationMRI Safety Information, document 702071/H/07 (05/23) — Institut Straumann AG, 2023-05. Accessed 28 Sep 2026.
- Regulatory recordFDA 510(k) K211109 — N1 TiUltra TCC Implant System (Nobel Biocare) — U.S. Food and Drug Administration, 2021-12-21. Accessed 28 Sep 2026.
- Manufacturer documentationStraumann Group Annual Report 2025 — Straumann Holding AG. Accessed 28 Sep 2026.
- Manufacturer documentationEnvista — Specialty Products & Technology (Nobel Biocare, Implant Direct, Alpha-Bio Tec) — Envista Holdings Corporation. Accessed 28 Sep 2026.
- Manufacturer documentationStraumann iEXCEL™ system (product page) — Institut Straumann AG. Accessed 28 Sep 2026.
- Regulatory recordFDA 510(k) K200586 — Straumann TLX Implant System (510(k) summary) — U.S. Food and Drug Administration, 2020-08-20. Accessed 28 Sep 2026.
- Manufacturer documentationStraumann® Zygomatic Implant System (product page) — Institut Straumann AG. Accessed 28 Sep 2026.
- Regulatory recordFDA 510(k) K243834 — NobelZygoma TiUltra Implant system — U.S. Food and Drug Administration, 2025-08-25. Accessed 28 Sep 2026.
- Manufacturer documentationStraumann® Pro Arch™ Fixed Solution — Institut Straumann AG. Accessed 28 Sep 2026.
- Manufacturer documentationStraumann® Guarantee — Dental Implant System (form 152.360) — Institut Straumann AG. Accessed 28 Sep 2026.
- Systematic reviewCamps-Font O et al. External, internal flat-to-flat and conical connections: systematic review and network meta-analysis — J Prosthet Dent, 2023. Accessed 28 Sep 2026.
- Systematic reviewSchoenbaum TR et al. Implant-abutment connections and marginal bone: systematic review of 45,347 implants — Int J Oral Maxillofac Implants, 2023. Accessed 28 Sep 2026.
- Consensus / guidelineHerrera D et al. Prevention and treatment of peri-implant diseases — EFP S3 level clinical practice guideline — J Clin Periodontol, 2023. Accessed 28 Sep 2026.